Comparison of the topical effect of 5% potassium hydroxide solution with cryotherapy in the treatment of patients with genital warts

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230417057941N1

Enrollment

Registered

2023-05-24

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital wart. Other predominantly sexually transmitted diseases, not elsewhere classifiedExcl.:molluscum contagiosum (B08.1)papilloma of cervix (D26.0)A63.0Anogenital (venereal) wartsA63.8Other specified predominantly sexually transmitted diseases

Interventions

Intervention 1: Intervention group:Treatment with 5% KOH solution, prepared by a pharmacist colleague in the Faculty of Pharmacy, is applied topically on the wart lesions using a swab by the patient u

Eligibility

Sex/Gender

All

Age

3 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with external genital warts whose number of lesions is less than 10 and the size of lesions is less than 1 cm

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Response to treatment: The ratio of the number of fully treated patients divided by the total number of patients in that group multiplied by 100. Timepoint: before starting treatment and at four-week intervals for a maximum of 12 weeks. Method of measurement: ???? ????? ?????? ?? ????? ?????? ????Reducing the number of wastes by observing the researcher.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatame Javame

Mashhad University of Medical Sciences

Javamef991@mums.ac.ir+98 51 3879 8073

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026